Welcome to our dedicated page for CoreWeave SEC filings (Ticker: CRWV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CoreWeave, Inc. filings document the regulatory record for an AI cloud infrastructure company listed on Nasdaq with Class A common stock. The company’s 8-K reports cover operating results, customer cloud-capacity agreements, private placements of equity securities, senior notes, credit facilities, and related guarantees or collateral arrangements.
Proxy materials disclose annual meeting matters, stockholder voting items, board governance, executive compensation, and equity-award information. Capital-structure filings describe senior unsecured notes due 2031, subsidiary guarantees, private placement registration rights, and debt facilities used to finance GPU servers and related infrastructure for customer contracts.
CoreWeave, Inc. insider reporting shows multiple entities associated with Chief Development Officer Brannin McBee trading Class A Common Stock on June 8, 2026. Family and grantor retained annuity trusts, including Canis Minor 2025 GRAT and Canis Major 2025 GRAT, reported open-market sales totaling 55,500 shares of Class A at prices around $100 per share. The filing also records derivative conversions labeled as code C, with the same total of 55,500 shares moving from Class B into Class A Common Stock through related trusts. A footnote states that at least one sale was effected under a Rule 10b5-1 trading plan adopted on March 5, 2026, indicating those trades were pre-scheduled rather than discretionary.
CoreWeave, Inc. Chief Development Officer Brannin McBee reported net sales of 194,500 shares of Class A Common Stock on June 8, 2026, at weighted-average prices ranging from about $98.60 to $104.25 per share, after converting 134,766 Class B shares into Class A. Some sales were executed indirectly through his spouse and related trusts, and at least one sale was effected under a Rule 10b5-1 trading plan adopted on March 5, 2026.
HUTCHINS GLENN H reported acquisition or exercise transactions in this Form 4 filing.
CoreWeave, Inc. director Glenn H. Hutchins received a grant of 2,532 restricted stock units on June 8, 2026 as equity compensation. Each RSU represents a contingent right to receive one share of Class A Common Stock upon settlement.
The award will fully vest on the earlier of June 8, 2027 or the company’s next annual meeting of stockholders, provided Hutchins continues to serve the company through that date. Following this grant, he holds 2,532 RSUs directly, and these units do not expire; they either vest or are cancelled before vesting.
Boone Karen reported acquisition or exercise transactions in this Form 4 filing.
CoreWeave, Inc. director Karen Boone reported receiving a grant of restricted stock units tied to the company’s Class A common stock. On June 8, 2026, she was awarded 2,532 RSUs at no cash cost, each representing one share upon settlement.
The RSUs will fully vest on the earlier of June 8, 2027 or CoreWeave’s next annual stockholder meeting, as long as she continues serving the company through that date. These units do not expire; they will either vest or be cancelled before vesting. After this grant, her reported derivative holdings consist of 2,532 RSUs.
CRWV filing lists multiple planned resale transactions of Common stock by affiliated holders under broker arrangements, with specific sales executed under 10b5-1 plans on dates in 2026. The schedule enumerates daily share amounts and gross proceeds for each transaction.
CRWV notice of proposed sales of Common Stock by multiple holders under scheduled 10b5-1 plans. The filing lists numerous sale notices by entities and individuals, including West Clay Capital LLC (493,600 shares on 04/01/2026) and Brian Venturo (61,539 shares on 06/03/2026), with dollar amounts provided per trade. These are Form 144 sale notifications of previously arranged dispositions; timing and cumulative program limits are presented as individual sale entries.
CoreWeave, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on June 8, 2026. Stockholders representing 1,233,902,447 votes, or approximately 85.51% of the combined voting power of Class A and Class B shares, were present, establishing a quorum.
Stockholders elected Michael Intrator as a Class I director to serve until the 2029 annual meeting, ratified Deloitte & Touche LLP as independent auditor for the year ending December 31, 2026, and approved on a non-binding basis the compensation of the named executive officers.
They also advised that future advisory votes on executive compensation should be held every year. The board confirmed it will continue to hold an annual nonbinding advisory vote on named executive officer compensation until the next required frequency vote.
CRWV discloses multiple 10b5-1 sales of Common shares by affiliated holders, primarily Michael Intrator and Omnadora Capital LLC. The entries list repeated planned sales across spring 2026 under Rule 10b5-1 arrangements.
Examples shown include a sale of 200,000 shares by Michael Intrator on 06/02/2026 and a sale of 107,692 shares by Omnadora Capital LLC on 06/02/2026. Multiple earlier sales between 03/11/2026 and 06/02/2026 are also recorded.
CRWV proposed resale notice: A filer submitted a Rule 144 notice reporting an intended sale of 200,000 common shares of CRWV. The filing lists multiple recent sales executed under 10b5-1 plans by related parties, with transaction dates and dollar amounts shown through 06/09/2026.
Company submitted a Form 144 notice to sell 12,500 shares of Common stock. The filing lists numerous prior 10b5-1 sales by related holders across March–May 2026, with individual transactions ranging from several thousand to hundreds of thousands of shares. The filing records the proposed sale on 06/08/2026.